This proposed rule focuses primarily on PMTA overview techniques and information needs, notably with respect to application acceptance and filing. An application may possibly meet up with the acceptance and filing specifications, but still deficiency crucial info that FDA wants to determine no matter whether it should really challenge a promoting b